Bio & Pharmaceuticals

Print
NJ: BAP Pharma Opens U.S. HQ in Landing; Its First outside the U.K.

2 Feb, 2016


BAP Pharma, an award winning UK-based specialist supplier of comparators for clinical trials, announced the opening of its new U.S. headquarters in Landing, New Jersey. The new headquarters is the company’s first location in the U.S.

BAP Pharma manages the clinical trial supply process including sourcing, delivery and customized solutions to provide seamless service to its clients, which include some of the UK’s top pharmaceutical companies. The decision to expand its operations to New Jersey was made in response to the company’s rapid growth, according to founder and Managing Director, Dr. Bashir Parkar. Pharmaceutical industry veteran Lucas Nigro will manage the U.S. headquarters.

“Since 2011, BAP Pharma has been establishing itself as a global leader in the clinical trial supply sector based on attention to quality and best-in-class client service,” said Parkar. “The opening of our U.S. headquarters in New Jersey is an important milestone for our company and will enhance our ability to provide fast, seamless service to our clients.”

Parkar visited New Jersey during 2015 in search of a U.S. location. Choose New Jersey, a nonprofit economic development organization charged with business attraction and marketing the State, and its partners assisted Parkar in identifying real estate. BAP Pharma chose to lease a facility in Landing, which it has equipped with state of the art, fully enclosed temperature controlled ambient and cold room storage facilities.

“The facility and location proved a perfect fit for our company,” said Parkar. “Its proximity to a significant number of global pharmaceutical and biotechnology companies, including our current clients, made it particularly attractive. New Jersey’s excellent transportation network also enhances our ability to deliver products quickly and efficiently throughout the region and around the world.”

“We are excited to welcome BAP Pharma to the State’s thriving life sciences community,” said Michele Brown, President and CEO of Choose New Jersey. “Like New Jersey, the UK is a global leader in the life sciences. We’ve established strategic relations in this market through business trips and lead generation activities. New Jersey is ideally positioned to be the landing pad for international firms, based on its location in the heart of the Northeast, its diverse and talented labor pool, and the presence of the world’s top pharma and biotech companies.”

In addition to the support BAP Pharma received from Choose New Jersey, the company accessed a variety of resources in the U.S. and U.K. The company hired key personnel through the assistance of the Life Sciences Talent Network, managed by BioNJ; the New Jersey Business Action Center made introductions to State regulatory agencies; Select USA provided guidance on establishing and operating a business in the U.S.; and UK Trade & Investment made valuable connections in the U.S. market.

BAP Pharma will celebrate this significant landmark with an official ribbon cutting ceremony planned this spring.

Print